查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1859749

全球人工器官市场预测（至2032年）：按器官类型、通路、技术、最终用户和地区分類的分析

Artificial Organs Market Forecasts to 2032 - Global Analysis By Organ Type (Artificial Heart, Artificial Eye, Artificial Kidney, Artificial Pancreas and Other Organ Types), Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 预测，全球人造器官市场规模预计在 2025 年达到 278 亿美元，到 2032 年将达到 525 亿美元，预测期内复合年增长率为 9.5%。

人工器官是指旨在替代或辅助受损或缺失的生物器官功能的人工装置或组织。这些人工器官​​通常植入人体，以恢復血液过滤、氧气输送和荷尔蒙调节等重要功能。常见的例子包括人工心臟、人工肾臟、人工肺部和人工肝臟。这些人工器官​​采用高度生物相容性材料製成，以最大限度地减少排斥反应，并且通常会整合感测器和泵浦等先进技术。对于等待器官移植或合格器官捐赠条件的患者而言，人工器官是挽救生命的有效方案，在提高生存率和生活品质的同时，也有助于缓解全球器官捐赠短缺的问题。

慢性病增多

在全球范围内，糖尿病、心血管疾病和肾衰竭等慢性疾病负担日益加重，是推动人工器官市场发展的主要因素。由于这些疾病往往会导致器官衰竭，因此对人工器官的需求不断增长。人口老化和生活方式相关的健康问题也进一步加剧了这一趋势。对于等待器官移植时间漫长的患者而言，人工器官提供了一种挽救生命的选择，使其成为现代医疗保健体系的重要组成部分，致力于提高患者的生存率和生活质量，从而推动了市场成长。

人工器官和移植手术高成本

儘管人工器官具有挽救生命的潜力，但其研发、製造和移植成本高昂，令许多人难以负担。这些费用，加上术后护理和维护，限制了人工器官在低收入和中等收入社区的普及。保险覆盖范围的差异和严格的报销政策进一步阻碍了市场成长。成本障碍影响医疗服务提供者和患者，儘管人工器官具有临床益处，且在器官捐赠者短缺的情况下需求不断增长，但成本问题仍然延缓了人工器官技术的广泛应用。

技术进步

生物工程、机器人技术和材料科学的快速发展正在为人工器官市场创造新的机会。 3D列印、智慧感测器和生物相容性材料等技术创新正在提升人工器官的功能、耐久性和患者疗效。这些技术能够实现更精准的客製化和整合，降低排异反应率并提高性能。随着研究的加速，人工器官正变得更加高效和普及，为医疗保健领域的广泛应用打开了大门，并拓展了已开发经济体和新兴经济体的市场潜力。

严格的监管核准流程

由于监管核准流程复杂且耗时，人工器官市场面临许多挑战。为确保安全性、有效性和生物相容性，需要进行大规模的临床试验并提交相关文件，这导致产品上市延迟并增加研发成本。美国食品药物管理局（FDA）和欧洲药品管理局（EMA）等监管机构制定了严格的标准，小规模製造商很难应付这些规定。这些障碍会减缓创新步伐并限制市场准入，尤其对于新兴技术而言更是如此。

新冠疫情的影响：

新冠疫情扰乱了全球医疗卫生系统，影响了择期手术，并延误了器官移植。供应链中断以及资源重新分配至疫情应对，减缓了人工器官的生产与分发。然而，这场危机也凸显了建构具有韧性的医疗卫生基础设施以及加速发展数位化和远端监测技术的重要性。疫情后的復苏重新激发了需求，尤其是对维生设备的需求，这更加强调了在未来的医疗卫生规划中，需要可扩展、可及的人工器官解决方案来满足急性和慢性医疗需求。

预计在预测期内，医院板块将是最大的板块。

由于医院拥有先进的基础设施、技术精湛的医护人员以及进行复杂外科手术的能力，预计在预测期内，医院领域将占据最大的市场份额。这些机构是器官移植、术后照护和长期监测的主要中心。随着慢性病住院患者数量的增加以及对专科部门投资的不断增长，医院仍然是进行人工器官移植的理想场所。医院整合最尖端科技并遵守监管标准的能力进一步巩固了市场地位。

预计在预测期内，人工肾臟细分市场将实现最高的复合年增长率。

由于末期肾臟病率不断上升以及供肾数量有限，预计在预测期内，人工肾臟市场将呈现最高的成长率。穿戴式和植入式透析设备等技术创新正在改变患者照护，显着提升患者的活动能力和生活品质。公众意识的提高、有利的透析设备政策以及过滤和生物相容性方面的技术突破正在推动这些技术的普及应用。随着全球肾臟疾病的持续增长，人工肾臟正成为肾臟健康领域的重要解决方案。

比最大的地区

在预测期内，亚太地区预计将占据最大的市场份额，这主要得益于其庞大的人口基数、慢性病患病率的上升以及不断完善的医疗基础设施。中国、印度和日本等国家正大力投资医疗技术和器官替代疗法。政府措施、医疗旅游的兴起以及人们对器官衰竭治疗认识的提高，都推动了该地区的成长。主要製造商的存在以及有利的监管改革进一步巩固了亚太地区在市场上的主导地位。

复合年增长率最高的地区：

由于北美拥有先进的医疗保健体系、强大的研发能力以及创新医疗技术的高普及率，预计该地区在预测期内将呈现最高的复合年增长率。该地区受益于完善的健保体系、高素质的专业人才和有利的法规环境。器官衰竭病例的增加以及对个人化、高效治疗方案需求的成长正在推动市场扩张。生物技术公司与医疗服务提供者之间的策略合作也正在加速全部区域的产品开发和商业化进程。

免费客製化服务

订阅本报告的用户可享有以下免费客製化服务之一：

  • 公司简介
    • 对至多三家其他市场公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球人工器官市场（依器官类型划分）

  • 人工心臟
  • 人工眼
  • 人工肾臟
  • 人工胰臟
  • 人工肺
  • 人工电子耳
  • 其他的

6. 全球人工器官市场（依分销管道划分）

  • 直销
  • 经销商
  • 线上销售
  • 其他的

7. 全球人工器官市场（依技术划分）

  • 机器
  • 电子机械混合
  • 生物
  • 生物相容性材料
  • 其他的

8. 全球人工器官市场（依最终用户划分）

  • 医院
  • 研究所
  • 门诊手术中心
  • 居家照护
  • 诊所
  • 其他的

9. 全球人工器官市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Medtronic
  • Second Sight Medical Products
  • Abbott Laboratories
  • Ottobock
  • Boston Scientific
  • Ossur
  • Baxter
  • MED-EL
  • Abiomed
  • Getinge
  • Berlin Heart
  • Edwards Lifesciences
  • Cochlear
  • Ekso Bionics
  • CYBERDYNE
Product Code: SMRC31973

According to Stratistics MRC, the Global Artificial Organs Market is accounted for $27.8 billion in 2025 and is expected to reach $52.5 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Artificial organs are engineered devices or tissues designed to replace or support the function of damaged or missing biological organs. These synthetic substitutes are typically implanted into the human body to restore vital functions such as blood filtration, oxygenation, or hormone regulation. Common examples include artificial hearts, kidneys, lungs, and livers. They are constructed using biocompatible materials to minimize rejection and often integrate advanced technologies like sensors or pumps. Artificial organs serve as life-saving solutions for patients awaiting transplants or those ineligible for donor organs, offering improved survival rates and quality of life while addressing the global shortage of organ donors.

Market Dynamics:

Driver:

Growing Prevalence of Chronic Diseases

The increasing global burden of chronic diseases such as diabetes, cardiovascular disorders, and kidney failure is a major driver of the artificial organs market. As these conditions often lead to organ dysfunction, the demand for artificial replacements continues to rise. Aging populations and lifestyle-related health issues further contribute to this trend. Artificial organs offer life-saving alternatives for patients who face long transplant wait times, making them essential in modern healthcare systems focused on improving survival and quality of life. Thus, it drives the growth of the market.

Restraint:

High Cost of Artificial Organs and Implantation Procedures

Despite their life-saving potential, artificial organs remain financially inaccessible for many due to high development, manufacturing, and surgical implantation costs. These expenses are compounded by post-operative care and maintenance, limiting adoption in low- and middle-income regions. Insurance coverage gaps and limited reimbursement policies further hinder market growth. The cost barrier affects both healthcare providers and patients, slowing widespread integration of artificial organ technologies despite their clinical benefits and growing demand in the face of organ donor shortages.

Opportunity:

Advancements in technology

Rapid advancements in bioengineering, robotics, and material science are creating new opportunities in the artificial organs market. Innovations such as 3D printing, smart sensors, and biocompatible materials are improving organ functionality, durability, and patient outcomes. These technologies enable more precise customization and integration, reducing rejection rates and enhancing performance. As research accelerates, artificial organs are becoming more efficient and accessible, opening doors for broader applications in healthcare and expanding the market's potential across both developed and emerging economies.

Threat:

Stringent Regulatory Approval Processes

The artificial organs market faces significant challenges due to complex and lengthy regulatory approval processes. Ensuring safety, efficacy, and biocompatibility requires extensive clinical trials and documentation, which delays product launches and increases development costs. Regulatory bodies such as the FDA and EMA impose rigorous standards, and navigating these frameworks can be difficult for smaller manufacturers. These hurdles may slow innovation and limit market entry, especially for novel technologies.

Covid-19 Impact:

The COVID-19 pandemic disrupted healthcare systems globally, affecting elective surgeries and delaying organ implantations. Supply chain interruptions and resource reallocation toward pandemic response slowed production and distribution of artificial organs. However, the crisis also highlighted the importance of resilient healthcare infrastructure and accelerated digital and remote monitoring technologies. Post-pandemic recovery has reignited demand, especially for life-supporting devices, and reinforced the need for scalable, accessible artificial organ solutions to address both emergency and chronic care needs in future healthcare planning.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period, due to their advanced infrastructure, skilled personnel, and capacity to perform complex surgical procedures. These institutions serve as primary centers for organ implantation, post-operative care, and long-term monitoring. With rising patient admissions for chronic conditions and increased investment in specialized departments, hospitals remain the preferred setting for artificial organ deployment. Their ability to integrate cutting-edge technologies and comply with regulatory standards further strengthens their market.

The artificial kidney segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the artificial kidney segment is predicted to witness the highest growth rate, due to growing prevalence of end-stage renal disease and limited availability of donor kidneys. Innovations in wearable and implantable dialysis devices are transforming patient care, offering mobility and improved quality of life. Rising awareness, supportive reimbursement policies, and technological breakthroughs in filtration and biocompatibility are fueling adoption. As kidney-related disorders continue to rise globally, artificial kidneys are becoming a critical solution in renal healthcare.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its vast population, rising incidence of chronic diseases, and expanding healthcare infrastructure. Countries like China, India, and Japan are investing heavily in medical technology and organ replacement therapies. Government initiatives, growing medical tourism, and increasing awareness about organ failure treatments contribute to regional growth. The presence of key manufacturers and favorable regulatory reforms further position Asia Pacific as a dominant force in the market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare systems, strong R&D capabilities, and high adoption of innovative medical technologies. The region benefits from robust reimbursement frameworks, skilled professionals, and supportive regulatory environments. Rising cases of organ failure, coupled with growing demand for personalized and efficient treatment options, are fueling market expansion. Strategic collaborations between biotech firms and healthcare providers also accelerate product development and commercialization across the region.

Key players in the market

Some of the key players in Artificial Organs Market include Medtronic, Second Sight Medical Products, Abbott Laboratories, Ottobock, Boston Scientific, Ossur, Baxter, MED-EL, Abiomed, Getinge, Berlin Heart, Edwards Lifesciences, Cochlear, Ekso Bionics, and CYBERDYNE.

Key Developments:

In October 2025, Medtronic is teaming up with DASI Simulations to apply AI-driven predictive modeling and digital-twin technology to the field of transcatheter aortic valve replacement (TAVR). The collaboration aims to deliver device-agnostic, patient-specific treatment planning that enhances procedural precision, anticipates complications, and supports personalized outcomes in structural heart interventions.

In July 2025, Medtronic and Philips have entered a multi-year strategic partnership to broaden access to advanced patient-monitoring technology, integrating Medtronic's sensor expertise into Philips' monitoring systems. This collaboration aims to enhance global clinician tools, streamline procurement of ECG/NIBP supplies, and improve patient-care outcomes through validated, combined solutions.

Organ Types Covered:

  • Artificial Heart
  • Artificial Eye
  • Artificial Kidney
  • Artificial Pancreas
  • Artificial Lung
  • Cochlear Implants
  • Other Organ Types

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Sales
  • Other Distribution Channels

Technologies Covered:

  • Mechanical
  • Electro-Mechanical Hybrid
  • Biological
  • Biocompatible Materials
  • Other Technologies

End Users Covered:

  • Hospitals
  • Research Institutions
  • Ambulatory Surgical Centers
  • Homecare
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Artificial Organs Market, By Organ Type

  • 5.1 Introduction
  • 5.2 Artificial Heart
  • 5.3 Artificial Eye
  • 5.4 Artificial Kidney
  • 5.5 Artificial Pancreas
  • 5.6 Artificial Lung
  • 5.7 Cochlear Implants
  • 5.8 Other Organ Types

6 Global Artificial Organs Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Direct Sales
  • 6.3 Distributors
  • 6.4 Online Sales
  • 6.5 Other Distribution Channels

7 Global Artificial Organs Market, By Technology

  • 7.1 Introduction
  • 7.2 Mechanical
  • 7.3 Electro-Mechanical Hybrid
  • 7.4 Biological
  • 7.5 Biocompatible Materials
  • 7.6 Other Technologies

8 Global Artificial Organs Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research Institutions
  • 8.4 Ambulatory Surgical Centers
  • 8.5 Homecare
  • 8.6 Clinics
  • 8.7 Other End Users

9 Global Artificial Organs Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic
  • 11.2 Second Sight Medical Products
  • 11.3 Abbott Laboratories
  • 11.4 Ottobock
  • 11.5 Boston Scientific
  • 11.6 Ossur
  • 11.7 Baxter
  • 11.8 MED-EL
  • 11.9 Abiomed
  • 11.10 Getinge
  • 11.11 Berlin Heart
  • 11.12 Edwards Lifesciences
  • 11.13 Cochlear
  • 11.14 Ekso Bionics
  • 11.15 CYBERDYNE

List of Tables

  • Table 1 Global Artificial Organs Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Artificial Organs Market Outlook, By Organ Type (2024-2032) ($MN)
  • Table 3 Global Artificial Organs Market Outlook, By Artificial Heart (2024-2032) ($MN)
  • Table 4 Global Artificial Organs Market Outlook, By Artificial Eye (2024-2032) ($MN)
  • Table 5 Global Artificial Organs Market Outlook, By Artificial Kidney (2024-2032) ($MN)
  • Table 6 Global Artificial Organs Market Outlook, By Artificial Pancreas (2024-2032) ($MN)
  • Table 7 Global Artificial Organs Market Outlook, By Artificial Lung (2024-2032) ($MN)
  • Table 8 Global Artificial Organs Market Outlook, By Cochlear Implants (2024-2032) ($MN)
  • Table 9 Global Artificial Organs Market Outlook, By Other Organ Types (2024-2032) ($MN)
  • Table 10 Global Artificial Organs Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 11 Global Artificial Organs Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 12 Global Artificial Organs Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 13 Global Artificial Organs Market Outlook, By Online Sales (2024-2032) ($MN)
  • Table 14 Global Artificial Organs Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 15 Global Artificial Organs Market Outlook, By Technology (2024-2032) ($MN)
  • Table 16 Global Artificial Organs Market Outlook, By Mechanical (2024-2032) ($MN)
  • Table 17 Global Artificial Organs Market Outlook, By Electro-Mechanical Hybrid (2024-2032) ($MN)
  • Table 18 Global Artificial Organs Market Outlook, By Biological (2024-2032) ($MN)
  • Table 19 Global Artificial Organs Market Outlook, By Biocompatible Materials (2024-2032) ($MN)
  • Table 20 Global Artificial Organs Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 21 Global Artificial Organs Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Artificial Organs Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Artificial Organs Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 24 Global Artificial Organs Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 25 Global Artificial Organs Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 26 Global Artificial Organs Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 27 Global Artificial Organs Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.